Quantcast

Latest Cerebral aneurysm Stories

2010-08-03 09:00:00

TUSTIN, Calif., Aug. 3 /PRNewswire/ -- MicroVention, Inc., a leading developer, manufacturer and marketer of interventional neurovascular devices, announced today that the final 18-month follow-up data in an international study showed that its innovative HydroCoil® Embolic System for treating cerebral aneurysms reduced recurrence and retreatment rates and provided improved outcomes in study patients when compared to bare platinum coils, which are considered the standard...

2010-08-02 15:44:04

Results from a new study suggest that oral contraceptives and hormone replacement therapy (HRT) may yield additional benefit of protecting against the formation and rupture of brain aneurysms in women. The findings from this first-of-its-kind study by a neurointerventional expert from Rush University Medical Center were presented at the Society of Neurointerventional Surgery (SNIS) 7th annual meeting. According to the lead author of the study, Dr. Michael Chen, neurointerventionalist at Rush,...

2010-07-30 09:34:00

Findings Announced at the Society of NeuroInterventional Surgery (SNIS) 7th Annual Meeting CARLSBAD, Calif., July 30 /PRNewswire-USNewswire/ -- Results from a retrospective, case-control study presented today at the Society of NeuroInterventional Surgery (SNIS) 7th Annual Meeting could have significant implications for women at risk of brain aneurysms as data shows that oral contraceptives (OC) and hormone replacement therapy (HRT) may yield the additional benefit of protecting against...

2010-07-12 07:30:00

NEW BRUNSWICK, N.J. and SAN JOSE, Calif., July 12 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) and Micrus Endovascular Corporation (Nasdaq: MEND), a global developer and manufacturer of minimally invasive devices to address hemorrhagic and ischemic stroke, today announced a definitive agreement whereby Micrus Endovascular will be acquired in a cash for stock exchange. Under the terms of the agreement, Micrus Endovascular stockholders will receive at closing $23.40 for each...

2010-06-09 14:22:00

Surgeons at Johns Hopkins have safely and effectively operated inside the brains of a dozen patients by making a small entry incision through the natural creases of an eyelid to reach the skull and deep brain. They say access to the skull and brain through either lid, formally known as a transpalpebral orbitofrontal craniotomy, sharply contrasts with the more laborious, physically damaging and invasive, traditional means of entry used in brain surgery that requires opening the top half of the...

2010-05-13 12:22:00

ALISO VIEJO, Calif., May 13 /PRNewswire/ -- Sequent Medical, Inc. announced today that it has closed a $15.6 million Series B venture capital financing. The financing was led by Domain Associates, joined by existing investors Versant Ventures and US Venture Partners. Nimesh Shah of Domain will join Sequent's Board of Directors. "We are privileged to have such a high caliber group of investors, and would like to welcome both Domain Associates as an investor in Sequent and Nimesh Shah as...

2010-05-13 08:00:00

ALISO VIEJO, Calif., May 13 /PRNewswire/ -- Sequent Medical, Inc. announced today that it has closed a $15.6 million Series B venture capital financing. The financing was led by Domain Associates, joined by existing investors Versant Ventures and US Venture Partners. Nimesh Shah of Domain will join Sequent's Board of Directors. "We are privileged to have such a high caliber group of investors, and would like to welcome both Domain Associates as an investor in Sequent and Nimesh Shah as...

2010-05-04 11:17:41

A new study shows that people with a common heart defect may also be more likely to have brain aneurysms. The study is published in the May 4, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology. Up to two percent of the population is born with the heart defect called a bicuspid aortic valve (BAV). The aortic valve allows blood to flow from the heart to the aorta. It normally has three flaps that open and close to regulate blood flow. In...

2010-04-22 05:00:00

SAN DIEGO, April 22 /PRNewswire/ -- Valor Medical's CEO, H. Clark Adams, announced today that Valor's European clinical trial was finalized with 30 patients treated. Mr. Adams stated, "The trial took longer than expected because there are current approved therapies which were used as a first line of therapy. Patients who were enrolled to be treated with Valor's Neucrylate were not always acceptable candidates for these standard-of-care therapies. Basically, the aneurysms in the trial...

2010-04-05 07:01:29

In the largest genome-wide study of brain aneurysms ever conducted, an international team led by researchers at the Yale School of Medicine has identified three new genetic variants that increase a person's risk for developing this deadly disease. The massive study of intracranial aneurysms involved more than 20,000 subjects and was published in the April 4 online edition of the journal Nature Genetics. The new study, the second by Yale researchers published within the last 15 months, brings...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related